We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for tezacaftor, ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd)
Active ingredients
tezacaftor, ivacaftor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
For the treatment of patients with cystic fibrosis
Therapeutic area
Respiratory